Inventurus Knowledge Solutions Limited (NSE:IKS)
India · Delayed Price · Currency is INR 1,579.40
-11.60 (-0.73%)
Jul 22, 2025, 3:30 PM IST
NSE:IKS Revenue
In the fiscal year ending March 31, 2025, Inventurus Knowledge Solutions had annual revenue of 26.64B INR with 46.54% growth. Inventurus Knowledge Solutions had revenue of 7.24B in the quarter ending March 31, 2025, with 16.77% growth.
Revenue
26.64B
Revenue Growth
+46.54%
P/S Ratio
10.25
Revenue / Employee
2.07M
Employees
12,862
Market Cap
273.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.64B | 8.46B | 46.54% |
| Mar 31, 2024 | 18.18B | 7.87B | 76.28% |
| Mar 31, 2023 | 10.31B | 2.68B | 35.05% |
| Mar 31, 2022 | 7.64B | 2.11B | 38.20% |
| Mar 31, 2021 | 5.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |